The revenue stands at ₹7,474.66 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.29 per cent from ₹7,167.52 crore. This corresponds to a year-on-year *(YoY) growth of 31.89 per cent.
Operating Profit stands at ₹2,354.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 28.28 per cent from ₹1,835.28 crore. This corresponds to a year-on-year *(YoY) growth of 78.19 per cent.
PBDT stands at ₹2,374.79 crore, reflecting a quarter-on-quarter *(QoQ) increase of 29.42 per cent from ₹1,835.00 crore. This corresponds to a year-on-year *(YoY) growth of 84.23 per cent.
Profit Before Tax stands at ₹1,928.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 26.67 per cent from ₹1,522.04 crore. This corresponds to a year-on-year *(YoY) growth of 115.22 per cent.
Net Profit stands at ₹1,468.67 crore, reflecting a quarter-on-quarter *(QoQ) increase of 24.41 per cent from ₹1,180.51 crore. This represents a 87.72 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | 3.43% | 2.85% | 10.11% | 8.70% | 19.15% | 25.25% |
| Cipla | 0.15% | 0.34% | 4.34% | 21.43% | -4.01% | -3.64% |
| Zydus Lifesci. | 3.54% | 1.73% | 5.12% | 31.70% | 23.78% | 13.99% |
| Dr Reddy's Labs | 2.54% | -0.13% | 8.48% | 12.93% | 10.07% | 5.32% |
| Mankind Pharma | 2.06% | 1.84% | 7.51% | 25.36% | 15.40% | 3.77% |
| Aurobindo Pharma | 3.85% | 4.60% | 10.69% | 20.92% | 34.19% | 36.07% |
| Laurus Labs | 1.21% | 2.71% | 8.16% | 45.85% | 40.00% | 98.93% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal